Triple-Negative Breast Cancer: Progress of Immune-Based Combinations and Novel Targeted Therapies

Download the slides from an expert-led Webinar to review the latest strategies for integrating immune checkpoint inhibitors and targeted therapies into the continuum of TNBC from early-stage disesase through metastatic setting.

Share

Program Content

Activities

ICI in Advanced TNBC
Immune Checkpoint Inhibitor in Advanced TNBC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 30, 2020

Expires: June 29, 2021

ICI in Early-Stage TNBC
Immune Checkpoint Inhibitor in Early-Stage TNBC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 30, 2020

Expires: June 29, 2021

irAEs in TNBC
Understanding Immune-Related Adverse Events
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 30, 2020

Expires: June 29, 2021

Faculty

cover img faculity

Heather McArthur, MD, MPH

Associate Professor
Department of Internal Medicine
Clinical Director, Breast Cancer Program
Komen Distinguished Chair in Clinical Breast Cancer Research
UT Southwestern Medical Center
Dallas, Texas

cover img faculity

Rita Nanda, MD

Associate Professor of Medicine
Director, Breast Oncology
Section of Hematology/Oncology
Department of Medicine
The University of Chicago
Chicago, Illinois

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Genentech, a member of the Roche Group